Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Seigne, Christelle ^a   Fontanière, Sandra ^a,b   Carreira, Christine ^a,b   Lu, Jieli ^a,f   Tong, Wei Ming ^b,c   Fontanière, Bernard ^a   Wang, Zhao Qi ^b,d   Zhang, Chang X ^a,f   Frappart, Lucien ^e  

^a CENTRE LÉON BÉRARD   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d FRITZ LIPMANN INSTITUTE   (Germany)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; METHIONINE; PROTEIN P63; MEN1 PROTEIN, MOUSE; ONCOPROTEIN; PHOSPHOPROTEIN; TRANSACTIVATOR PROTEIN; TRP63 PROTEIN, MOUSE;

ADENOCARCINOMA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE INACTIVATION; GENE TARGETING; GENETIC HETEROGENEITY; HETEROZYGOSITY; HETEROZYGOSITY LOSS; IMMUNOHISTOCHEMISTRY; MALE; MEN1 GENE; MOUSE; MUTANT; NONHUMAN; ONCOGENE; PROSTATE CANCER; AGING; ANIMAL; C57BL MOUSE; ENZYME IMMUNOASSAY; GENETICS; HETEROZYGOTE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; SOUTHERN BLOTTING;

ADENOCARCINOMA; AGING; ANIMALS; BLOTTING, SOUTHERN; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HETEROZYGOTE; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED C57BL; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANDROGEN; TRANS-ACTIVATORS;

EID: 77954875340     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-395     Document Type: Article

References (40)

1. Thakker RV. Multiple endocrine neoplasia--syndromes of the twentieth century. J Clin Endocrinol Metab 1998, 83(8):2617-2620. 10.1210/jc.83.8.2617, 9709920.
2. Boni R, Vortmeyer AO, Pack S, Park WS, Burg G, Hofbauer G, Darling T, Liotta L, Zhuang Z. Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol 1998, 111(3):539-540. 10.1046/j.1523-1747.1998.00317.x, 9740255.
3. Hofmann M, Schilling T, Heilmann P, Haisken O, Wuster C, Brandi ML, Ziegler R, Nawroth PP. [Multiple endocrine neoplasia associated with multiple lipomas]. Med Klin (Munich) 1998, 93(9):546-549. 10.1007/BF03042664, 9792021.
4. Yang Y, Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol 2007, 265-266:34-41. 10.1016/j.mce.2006.12.032, 1919399, 17222504.
5. Bertolino P, Radovanovic I, Casse H, Aguzzi A, Wang ZQ, Zhang CX. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech Dev 2003, 120(5):549-560. 10.1016/S0925-4773(03)00039-X, 12782272.
6. Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol 2003, 17(9):1880-1892. 10.1210/me.2003-0154, 12819299.
7. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 2001, 98(3):1118-1123. 10.1073/pnas.98.3.1118, 14718, 11158604.
8. Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK, Kay GF. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int J Cancer 2007, 120(2):259-267. 10.1002/ijc.22288, 17044021.
9. Dreijerink KM, Mulder KW, Winkler GS, Hoppener JW, Lips CJ, Timmers HTM. Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 2006, 66(9):4929-4935. 10.1158/0008-5472.CAN-05-4461, 16651450.
10. Dreijerink KMA, Varier RA, van Beekum O, Jeninga EH, Hoppener JWM, Lips CJM, Kummer JA, Kalkhoven E, Timmers HTM. The Multiple Endocrine Neoplasia type 1 (MEN1) tumor suppressor regulates PPAR{gamma}-dependent adipocyte differentiation. Mol Cell Biol 2009, 29(18):5060-5069. MCB.01001-01008.
11. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 2005, 102(3):749-754. 10.1073/pnas.0408836102, 545577, 15640349.
12. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M, Kim SK. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 2005, 102(41):14659-14664. 10.1073/pnas.0503484102, 1253549, 16195383.
13. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004, 64(6):2270-2305. 10.1158/0008-5472.CAN-03-0946, 15026373.
14. Liu Y, Mo JQ, Hu Q, Boivin G, Levin L, Lu S, Yang D, Dong Z. Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer. Cancer Res 2008, 68(15):6396-6406. 10.1158/0008-5472.CAN-08-0645, 2730641, 18676865.
15. Weinstein MH, Signoretti S, Loda M. Diagnostic Utility of Immunohistochemical Staining for p63, a Sensitive Marker of Prostatic Basal Cells. Mod Pathol 2002, 15(12):1302-1308. 10.1097/01.MP.0000038460.95912.6E, 12481011.
16. Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y, Koji T. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J Clin Endocrinol Metab 2003, 88(3):1333-1340. 10.1210/jc.2002-021015, 12629127.
17. Svensson J, Kindblom J, Shao R, Moverare-Skrtic S, Lagerquist MK, Andersson N, Sjogren K, Venken K, Vanderschueren D, Jansson JO, Isaksson O, Ohlsson C. Liver-derived IGF1 enhances the androgenic response in prostate. J Endocrinol 2008, 199(3):489-497. 10.1677/JOE-08-0406, 18827067.
18. Ishii K, Imanaka-Yoshida K, Yoshida T, Sugimura Y. Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation. Developmental Biology 2008, 324(2):310-319. 10.1016/j.ydbio.2008.09.029, 18950615.
19. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, P Pandolfi P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 2001, 27(2):222-224. 10.1038/84879, 11175795.
20. Macri E, Loda M. Role of p27 in prostate carcinogenesis. Cancer Metastasis Rev 1998, 17(4):337-344. 10.1023/A:1006133620914, 10453277.
21. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP. Pten dose dictates cancer progression in the prostate. PLoS Biol 2003, 1(3):E59. 10.1371/journal.pbio.0000059, 270016, 14691534.
22. Zhong C, Saribekyan G, Liao C-P, Cohen MB, Roy-Burman P. Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis. Cancer Res 2006, 66(4):2188-2194. 10.1158/0008-5472.CAN-05-3440, 16489020.
23. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM. Roles for Nkx3.1 in prostate development and cancer. Genes Dev 1999, 13(8):966-977. 10.1101/gad.13.8.966, 316645, 10215624.
24. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(5):2884-2889. 10.1073/pnas.042688999, 122442, 11854455.
25. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M, Lee H, Shih WJ, Cardiff RD, Shen MM, Abate-Shen C. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 2004, 101(49):17204-17209. 10.1073/pnas.0407693101, 535400, 15569926.
26. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Research 2000, 60:6111-6115.
27. Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis 2009, 12(2):184-91. 10.1038/pcan.2008.45, 2844124, 18779856.
28. Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, Niki S, Murazawa C, Nakajima H, Kohno N, Yamashita H, Iwase H, Hayashi SI, Ishida T, Yamauchi A. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance. Breast Cancer Res Treat 2009, 122(2):395-407. 10.1007/s10549-009-0581-0, 19847644.
29. Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C. Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4. Journal of Biological Chemistry 2002, 277:43749-43756. 10.1074/jbc.M205603200, 12226080.
30. Litvinov IV, De Marzo AM, Isaacs JT. Is the Achilles' Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?. J Clin Endocrinol Metab 2003, 88(7):2972-2982. 10.1210/jc.2002-022038, 12843129.
31. Xu Y, Chen SY, Ross KN, Balk SP. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Research 2006, 66(15):7783-92. 10.1158/0008-5472.CAN-05-4472, 16885382.
32. Matzuk MM, Finegold MJ, Su J-GJ, Hsueh AJW, Bradley A. [alpha]-lnhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992, 360(6402):313-319. 10.1038/360313a0, 1448148.
33. Behringer RR, Finegold MJ, Cate RL. Müllerian-inhibiting substance function during mammalian sexual development. Cell 1994, 79(3):415-425. 10.1016/0092-8674(94)90251-8, 7954809.
34. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR. Synergistic effects of inhibins and mullerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol 1995, 9(10):1337-1345. 10.1210/me.9.10.1337, 8544842.
35. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes & Development 1996, 10(20):2577-2587.
36. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity. Mol Cell Biol 2000, 20(16):6147-6158. 10.1128/MCB.20.16.6147-6158.2000, 86090, 10913196.
37. Hussein N, Lu J, Casse H, Fontaniere S, Morera AM, Guittot SM, Calender A, Di Clemente N, Zhang CX. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice. Endocr Relat Cancer 2008, 15(1):217-227. 10.1677/ERC-06-0046, 18310289.
38. Hussein N, Casse H, Fontaniere S, Morera AM, Asensio MJ, Bakeli S, Lu JL, Coste I, Di Clemente N, Bertolino P, Zhang CX. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis. Eur J Cancer 2007, 43(2):402-414. 10.1016/j.ejca.2006.08.038, 17184987.
39. Fontaniere S, Casse H, Bertolino P, Zhang CX. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice. Fam Cancer 2006, 5(1):49-54. 10.1007/s10689-005-2575-3, 16528608.
40. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008, 40(3):310-315. 10.1038/ng.91, 18264096.